CN1579482A - Blood-supplementing traditional Chinese medicine preparation and its production method - Google Patents
Blood-supplementing traditional Chinese medicine preparation and its production method Download PDFInfo
- Publication number
- CN1579482A CN1579482A CN 200410013167 CN200410013167A CN1579482A CN 1579482 A CN1579482 A CN 1579482A CN 200410013167 CN200410013167 CN 200410013167 CN 200410013167 A CN200410013167 A CN 200410013167A CN 1579482 A CN1579482 A CN 1579482A
- Authority
- CN
- China
- Prior art keywords
- liquid
- blood
- ethanol
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 title abstract description 79
- 239000007788 liquid Substances 0.000 claims abstract description 94
- 210000004369 blood Anatomy 0.000 claims abstract description 66
- 239000008280 blood Substances 0.000 claims abstract description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 59
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 33
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002775 capsule Substances 0.000 claims abstract description 17
- 239000008187 granular material Substances 0.000 claims abstract description 13
- 238000001556 precipitation Methods 0.000 claims abstract description 5
- 239000003826 tablet Substances 0.000 claims abstract 2
- 239000000047 product Substances 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 15
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 238000011084 recovery Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 102000011759 adducin Human genes 0.000 claims description 4
- 108010076723 adducin Proteins 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000012869 ethanol precipitation Methods 0.000 claims description 2
- 235000021022 fresh fruits Nutrition 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims 3
- 238000003379 elimination reaction Methods 0.000 claims 3
- 230000001256 tonic effect Effects 0.000 claims 2
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 41
- 230000007812 deficiency Effects 0.000 abstract description 39
- 241001289529 Fallopia multiflora Species 0.000 abstract description 24
- 206010033557 Palpitations Diseases 0.000 abstract description 24
- 235000013372 meat Nutrition 0.000 abstract description 24
- 210000000952 spleen Anatomy 0.000 abstract description 23
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 18
- 206010022437 insomnia Diseases 0.000 abstract description 18
- 206010016256 fatigue Diseases 0.000 abstract description 17
- 208000002173 dizziness Diseases 0.000 abstract description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 108010023302 HDL Cholesterol Proteins 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 210000003743 erythrocyte Anatomy 0.000 abstract description 7
- 206010027175 memory impairment Diseases 0.000 abstract description 7
- 102000001554 Hemoglobins Human genes 0.000 abstract description 5
- 108010054147 Hemoglobins Proteins 0.000 abstract description 5
- 230000001965 increasing effect Effects 0.000 abstract description 5
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 3
- 208000007502 anemia Diseases 0.000 abstract description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 24
- 238000000034 method Methods 0.000 description 22
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 16
- 239000000203 mixture Substances 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 239000004480 active ingredient Substances 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 208000011580 syndromic disease Diseases 0.000 description 11
- 238000012545 processing Methods 0.000 description 10
- 238000005728 strengthening Methods 0.000 description 9
- 230000036541 health Effects 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 235000014101 wine Nutrition 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 244000241838 Lycium barbarum Species 0.000 description 7
- 235000015459 Lycium barbarum Nutrition 0.000 description 7
- 235000008504 concentrate Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 210000003128 head Anatomy 0.000 description 7
- 206010000060 Abdominal distension Diseases 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000021251 pulses Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 description 5
- 235000008708 Morus alba Nutrition 0.000 description 5
- 240000000249 Morus alba Species 0.000 description 5
- 102000014190 Phosphatidylcholine-sterol O-acyltransferase Human genes 0.000 description 5
- 108010011964 Phosphatidylcholine-sterol O-acyltransferase Proteins 0.000 description 5
- 241000405911 Rehmannia glutinosa Species 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 235000015468 Lycium chinense Nutrition 0.000 description 4
- 240000005373 Panax quinquefolius Species 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 240000008866 Ziziphus nummularia Species 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- 241001061264 Astragalus Species 0.000 description 3
- 241000092665 Atractylodes macrocephala Species 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 240000002045 Guettarda speciosa Species 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 240000007049 Juglans regia Species 0.000 description 3
- 235000009496 Juglans regia Nutrition 0.000 description 3
- 241000830535 Ligustrum lucidum Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 235000006533 astragalus Nutrition 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000007215 black sesame Nutrition 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 235000020066 kaoliang wine Nutrition 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 235000020234 walnut Nutrition 0.000 description 3
- 240000000031 Achyranthes bidentata Species 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241001127714 Amomum Species 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 241000005787 Cistanche Species 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- 241000207901 Cuscuta Species 0.000 description 2
- 241000305491 Gastrodia elata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 208000036581 Haemorrhagic anaemia Diseases 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 241001530038 Pantherophis obsoletus Species 0.000 description 2
- 241000208966 Polygala Species 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241000234276 Curculigo Species 0.000 description 1
- 240000007371 Cuscuta campestris Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 206010018999 Haemorrhage subcutaneous Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 241001278833 Rosa laevigata Species 0.000 description 1
- 235000000661 Rosa laevigata Nutrition 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000913745 Spatholobus Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 206010043972 Tongue paralysis Diseases 0.000 description 1
- 206010043991 Tongue ulceration Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- -1 anthraquinone compound Chemical class 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 150000004338 hydroxy anthraquinones Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000001118 melena Diseases 0.000 description 1
- RSMUVYRMZCOLBH-UHFFFAOYSA-N metsulfuron methyl Chemical compound COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)NC1=NC(C)=NC(OC)=N1 RSMUVYRMZCOLBH-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 231100001019 reduced numbers of red blood cells Toxicity 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种补血中药制剂,该制剂由何首乌(赤、制)、龙眼肉(桂圆)等中药按照中医理论科学配制而成,其生产方法是将何首乌经高温高压后制成制何首乌,然后与龙眼肉混合,用水提,醇沉等现代制药生产工艺制成口服液、胶囊剂、颗粒剂、片剂。该药具有补益心脾、养气养血,提高血红蛋白、增加红细胞数量、提高高密度脂蛋白中的胆固醇(HDL-C)、降胆固醇、抗衰老等功效。主治心脾两虚、气血两虚证引起的心悸怔仲、健忘失眠,头晕目眩、倦怠乏力、贫血、高血脂等症,疗效显著。The invention provides a kind of traditional Chinese medicine preparation for enriching blood. The preparation is prepared scientifically from Chinese medicines such as Polygonum multiflorum (red, system), longan meat (longan), etc. according to the theory of traditional Chinese medicine. Then it is mixed with longan meat, extracted with water, and made into oral liquid, capsules, granules, and tablets by modern pharmaceutical production processes such as alcohol precipitation. The medicine has the effects of nourishing the heart and spleen, nourishing qi and blood, increasing hemoglobin, increasing the number of red blood cells, increasing cholesterol in high-density lipoprotein (HDL-C), lowering cholesterol, and anti-aging. It is mainly used to treat palpitations, forgetfulness, insomnia, dizziness, fatigue, anemia, hyperlipidemia and other diseases caused by deficiency of both heart and spleen, and deficiency of both qi and blood. The curative effect is remarkable.
Description
技术领域technical field
本发明涉及一种补血中药制剂,特别是治疗血虚、失眠的药物及其生产方法。The invention relates to a traditional Chinese medicine preparation for nourishing blood, in particular to a medicine for treating blood deficiency and insomnia and a production method thereof.
背景技术Background technique
中医所指的血虚,即现代医学中单位容积血液内的红血球数和血红蛋白量减少而言,包括缺铁性贫血、失血性贫血、溶血性贫血、抗贫血因子缺乏所致的贫血以及再生障碍性贫血等多种原因的贫血。中医统称为血虚。其原因很多,如失血、饮食失调、病后体虚等可耗伤气血,而致脾肾亏虚,不能生化气血所致。临床主要表现为面色萎黄、口唇苍白、头晕耳鸣、困倦乏力、心慌气短、失眠、血液红血球总数及血红蛋白减少。本病症临床上发病率很高,如产后、术后、病后,无论在农村或城市,均有大量的患者,是一种常见病。The deficiency of blood referred to in traditional Chinese medicine refers to the reduction of the number of red blood cells and the amount of hemoglobin per unit volume of blood in modern medicine, including iron deficiency anemia, hemorrhagic anemia, hemolytic anemia, anemia caused by lack of anti-anemia factors, and aplastic disorder anemia of various causes. The traditional Chinese medical science is collectively referred to as deficiency of blood. There are many reasons for it, such as blood loss, eating disorder, physical weakness after illness, etc., which can consume Qi and blood, and cause spleen and kidney deficiency, which cannot biochemically cause Qi and blood. The main clinical manifestations are sallow complexion, pale lips, dizziness, tinnitus, drowsiness, fatigue, palpitation, shortness of breath, insomnia, and decreased red blood cell count and hemoglobin. The clinical incidence of this disease is very high, such as postpartum, postoperative, and post-ill, no matter in rural areas or cities, there are a large number of patients, and it is a common disease.
对于血虚的治疗原则,当以补血为主,但同时注意补气,因益气可以生血。并须辨别脾虚与肾虚的主次,分别给予补脾和补肾的方法,以加强气血生化之原。气血两虚证,临床表现为面色苍白、头晕眼花、心慌气短、疲劳无力,治法是补气益血,代表方有十全大补汤加减,当归、黄芪、党参、白术,熟地、炙甘草,红枣。加减,心悸失眠,加熟枣仁、五味子。心脾两虚证。临床表现有心悸、神疲、食少,腹胀、便溏,舌溃脉弱。脾气虚弱,生血不足,或统摄无权,血溢脉外,均可导致心血亏虚。心血不足,无以气化,则脾气亦虚,两者常互相影响,或为心脾两虚证。心血不足,心失所养,则心悸;脾气不足,运化失健,故食少,腹胀,便溏。气血两虚,机能活动减退,故神疲乏力,舌质淡,脉细弱,皆为气血不足之症。治疗方法,益气补血,健脾养心,代表方为归心汤,有人参、黄芪、当归、白术、茯神、远志、龙眼肉、酸枣仁,炙甘草,生姜、大枣。肝肾阴虚证,临床表现有心悸、耳鸣、眩晕、烦热、口干,治法用滋养肝肾,方药可用女贞子、旱莲草、熟地、炙首乌,枸杞,炙龟板、煅磁石、当归、白芍。加减,皮下出血,加阿胶,仙鹤草。目前中成药,如生血丸,有鹿茸,黄柏,山药,白术(炒)、桑枝,白扁豆(炒),紫河车;十全大补丸,药有党参、白术、茯苓,炙甘草、当归、川芎、白芍、熟地、黄芪、肉桂。首乌丸,药有炙首乌,地黄,牛膝、桑椹,女贞子、暴旱莲,桑叶、黑芝麻,菟丝子、金樱子,浠签草、补骨脂、银花等。其它尚有当归养血丸。以上这些药物,组方复杂、成分复杂,除了成本高之外,在生产过程中,不易控制有效成分,产品稳定性能也难以控制,是中药现代化的主要难题。The principle of treatment for blood deficiency should be to replenish blood, but at the same time pay attention to replenishing qi, because replenishing qi can generate blood. It is also necessary to distinguish the primary and secondary of spleen deficiency and kidney deficiency, and give methods of nourishing the spleen and kidney respectively, so as to strengthen the origin of Qi and blood biochemistry. Qi and blood deficiency syndrome, the clinical manifestations are pale complexion, dizziness, shortness of breath, palpitation, and fatigue. Licorice, red dates. Addition and subtraction, palpitation and insomnia, add cooked jujube kernel and schisandra. Deficiency of both heart and spleen. Clinical manifestations include palpitations, fatigue, lack of appetite, abdominal distension, loose stools, tongue ulceration and weak pulse. Weakness of temper, insufficient production of blood, or lack of power to govern, and blood overflowing outside the veins can all lead to deficiency of heart blood. Insufficient effort, unable to transform into qi, then the spleen is also weak, the two often affect each other, or it is a syndrome of deficiency of both heart and spleen. Insufficient blood, the heart loses its nourishment, and palpitations; insufficiency of temper, impaired transportation and transformation, so less food, abdominal distension, and loose stools. Deficiency of both qi and blood, decreased functional activity, so mental fatigue, pale tongue, thready and weak pulse are all symptoms of insufficiency of qi and blood. The treatment method is to replenish qi and blood, invigorate the spleen and nourish the heart. The representative prescription is Guixin Decoction, which contains ginseng, astragalus, angelica, atractylodes macrocephala, Fushen, polygala, longan meat, jujube seed, roasted licorice, ginger, and jujube. Liver and kidney yin deficiency syndrome, clinical manifestations include palpitations, tinnitus, dizziness, dysphoria, dry mouth, the treatment method is to nourish the liver and kidney. Magnet, Angelica, Paeoniae Alba. Addition and subtraction, subcutaneous bleeding, plus donkey-hide gelatin, Agrimony. At present, Chinese patent medicines, such as Shengxue pills, include velvet antler, Phellodendron cortex, yam, Atractylodes macrocephala (stir-fried), mulberry branches, white lentils (stir-fried), Ziheche; Angelica, Chuanxiong, Paeoniae Alba, Rehmannia, Astragalus, Cinnamon. Shouwu Wan, medicines include sunburned Shouwu, Rehmannia glutinosa, Achyranthes bidentata, mulberry, Ligustrum lucidum, Eclipta chinensis, mulberry leaves, black sesame, Cuscuta, Rosa laevigata, Hezhicao, psoralen, silver flower, etc. Others include Angelica Yangxue Pills. The above-mentioned medicines have complex prescriptions and complex ingredients. In addition to high costs, it is difficult to control the active ingredients and product stability during the production process, which is the main problem in the modernization of traditional Chinese medicine.
经检索,我们还查到有关的专利文献如下:After searching, we also found relevant patent documents as follows:
1、<申请号>97103837<授权公告日>2000年02月16日<发明名称>一种治疗脑血管疾病的中成药<申请人>黄肇源 黄丹,四川省成都市蒲江县鹤山镇新区<文摘>本发明公开了一种治疗脑血管疾病的中成药,该药物是以下述药物组合物制成的药剂:黄芪:10-20份党参:10-20份何首乌:1-20份枸杞子:10-20份桂圆:10-20份山药:10-20份当归:10-20份石菖蒲:5-15份远志:5-15份益智仁:5-15份巴戟天:5-15份丹参:5-15份枣皮:5-15份菟丝子:5-15份天麻:5-15份熟地:15-25份珍珠母:25-35份佩兰:5-15份。它对脑血栓形成脑栓塞、脑出血、蛛网膜下腔出血与脑萎缩具有良好的治疗效果。1. <Application No.> 97103837 <Authorization Announcement Date> February 16, 2000 <Invention Name> A Chinese patent medicine for treating cerebrovascular diseases <Applicant> Huang Zhaoyuan Huang Dan, New District, Heshan Town, Pujiang County, Chengdu City, Sichuan Province <Abstract > The present invention discloses a Chinese patent medicine for treating cerebrovascular diseases. The medicine is a medicine made from the following pharmaceutical composition: Radix Astragali: 10-20 parts Codonopsis: 10-20 parts Polygonum multiflorum: 1-20 parts Lycium barbarum: 10 parts -20 parts of longan: 10-20 parts of Chinese yam: 10-20 parts of Chinese angelica: 10-20 parts Salvia: 5-15 parts Jujube skin: 5-15 parts Cuscuta: 5-15 parts Gastrodia elata: 5-15 parts Rehmannia glutinosa: 15-25 parts Mother-of-pearl: 25-35 parts Perrin: 5-15 parts. It has a good therapeutic effect on cerebral thrombosis, cerebral embolism, cerebral hemorrhage, subarachnoid hemorrhage and brain atrophy.
2、<申请号>95100046<发明名称>健美饮料及其制法<申请人>李存,北京市复外三里河三区43楼2门13号<文摘>一种健美饮料及其制法,选用山楂,何首乌,桔皮,薄荷,决明子,桂皮,桂元肉,杏干为原料,分别浸溶于水经过滤后成为原液,按一定比例配合,其中:山楂汁40-50%首乌汁28-30%姜汁2-3%桔皮汁3.5-4%薄荷汁5-6%决明子汁2-3%桂皮汁4.5-5%桂元肉汁3-6%杏干汁2-3%再添加少量白糖,醋或柠檬酸,香料,即制成健美饮料,含有多种氨基系,可降低血压和胆固醇,软化血管抑制肥胖的功能,老幼皆宜饮用。2. <Application No.> 95100046 <Invention Name> bodybuilding drink and its preparation method <Applicant> Li Cun, No. 13, Gate 2, 43rd Floor, Sanlihe District 3, Fuwai, Beijing <Abstract> A bodybuilding drink and its preparation method, Use hawthorn, fleece-flower root, orange peel, mint, cassia seed, cinnamon bark, longan meat, and dried apricot as raw materials. They are respectively soaked in water and filtered to become a stock solution. They are mixed in a certain proportion, among which: hawthorn juice 40-50% Shouwu juice 28-30% Ginger Juice 2-3% Orange Peel Juice 3.5-4% Mint Juice 5-6% Cassia Juice 2-3% Cinnamon Bark Juice 4.5-5% Guiyuan Gravy 3-6% Dried Apricot Juice 2-3% Add a small amount of sugar, vinegar or citric acid, and flavorings to make a fitness drink. It contains a variety of amino systems, which can lower blood pressure and cholesterol, soften blood vessels and inhibit obesity. It is suitable for all ages to drink.
3、<申请号>95100383<发明名称>发特龙保健饮料<申请人>曹世宣,湖北省武汉市武昌民主路47号<文摘>本发明公开了一种发特龙保健饮料,它由构杞9-10%、桑椹9-10%、茯芩9-10%、黑芝麻4-5%、核桃仁4-5%、黑枣11-12%、桂圆14-15%、黑大豆9-10%、侧柏叶3-6%、茨实9-10%、首乌13-16%、蔗糖粉按一定比例配制,然后将原料煎煮、浓缩、拌合、制粒、烘干。该发明设备简便、方法易行,具有滋阴、补虚、补肾、健脑、养血固精,促进头发细胞新陈代谢和毛发再生,有效地防止各类型的脱发、枯黄早白,对体虚无力、精神不振、失眠、神经衰弱有明显的康复保健作用。3. <Application No.> 95100383 <Invention Name> Fatelong Health Beverage <Applicant> Cao Shixuan, No. 47, Minzhu Road, Wuchang, Wuhan City, Hubei Province <Abstract> The present invention discloses a Fatelong health drink, which consists of 9-10%, 9-10% mulberry, 9-10% Poria, 4-5% black sesame, 4-5% walnut, 11-12% black date, 14-15% longan, 9-10% black soybean , 3-6% of arborvitae leaves, 9-10% of citrus fruit, 13-16% of Shouwu, and sucrose powder are prepared in a certain proportion, and then the raw materials are decocted, concentrated, mixed, granulated, and dried. The invention has simple equipment and easy method, and has the functions of nourishing yin, tonifying deficiency, tonifying kidney, strengthening brain, nourishing blood and consolidating essence, promoting hair cell metabolism and hair regeneration, and effectively preventing various types of hair loss, withered yellow and early graying, and is weak to the body. , depression, insomnia, and neurasthenia have obvious rehabilitation and health effects.
4、<申请号>94113767<授权公告日>2000年07月05日<发明名称>乌鸡枸杞营养补血酒<申请人>李发荣,安徽省合肥市史河路中药总厂宿舍2幢205室<文摘>一种乌鸡枸杞营养补血酒,所述的组方有以下成分和比例:乌鸡∶枸杞∶香菇∶红枣∶桂圆、当归、砂仁、女贞子、何首乌、陈皮、麦冬、白术、熟地、黄精、党参、白芍、甘草、川芎=1∶0.3~0.5∶0.05~0.1∶0.02~0.05∶0.002~0.005;(2)、萃取用白酒为酒度55度以上的粮食白酒,用量为:乌鸡∶白酒=1∶30~40,组方后先后用水和白酒萃取再加工而成。本发明溶补气血、健脾肺、益肝肾、导引行气、活血化瘀于一体,不仅适合健康人饮服,尤其适合血虚、心脾不足、肝肾亏损、各种贫血、癌症及多种慢性病患者服用。4. <Application Number>94113767<Authorization Announcement Date>July 05, 2000<Invention Name>Black-bone Chicken and Lycium Barbarum Nutritious Blood Tonic Wine<Applicant> Li Farong, Room 205, Building 2, Dormitory of General Factory of Traditional Chinese Medicine, Shihe Road, Hefei City, Anhui Province<Abstract >A black-bone chicken and wolfberry nutrition blood-replenishing wine, the prescription has the following ingredients and proportions: black-bone chicken: wolfberry: shiitake mushrooms: red dates: longan, angelica, amomum, ligustrum lucidum, Polygonum multiflorum, tangerine peel, Ophiopogon japonicus, Atractylodes macrocephala, Rehmannia glutinosa, Polygonatum, Codonopsis, Radix Paeoniae Alba, Licorice Root, Chuanxiong = 1: 0.3~0.5: 0.05~0.1: 0.02~0.05: 0.002~0.005; (2), the liquor used for extraction is grain liquor with an alcohol content above 55 degrees, and the dosage is: black-bone chicken : Liquor=1:30~40, it is made by extracting with water and liquor successively after formulating and then processing. The present invention dissolves and replenishes qi and blood, invigorates the spleen and lungs, nourishes the liver and kidneys, guides the circulation of qi, and promotes blood circulation and removes blood stasis. Patients with cancer and various chronic diseases take it.
5、<申请号>93120022<发明名称>美容保健口服液及膏<申请人>戴明昌,浙江省永嘉县桥头镇东行村<文摘>本发明涉及一种用中药食品:其原料的组成(重量)为:桂圆肉5-10%阿胶0.5-2%核桃肉10-20%杞子10-15%红枣(去核)10-20%制首乌5-10%黑芝麻10-15%珍珠粉0.2-0.8%蜂蜜25-35%,成分经科学配方加工成的一种服用的特殊美容功效的美容宝膏及口服液。具有补气血、美容颜、抗衰老,提高人体免疫力功效。每日坚持少量服用,45天以上,可使皮肤红润健康、细嫩光泽及抗皱和乌发的作用。5. <Application No.> 93120022 <Invention Name> beauty care oral liquid and ointment <Applicant> Dai Mingchang, Donghang Village, Qiaotou Town, Yongjia County, Zhejiang Province <Abstract> This invention relates to a food using traditional Chinese medicine: the composition of its raw materials ( Weight) is: longan meat 5-10% donkey-hide gelatin 0.5-2% walnut meat 10-20% wolfberry 10-15% red jujube (pitted) 10-20% shouwu 5-10% black sesame 10-15% pearl Powder 0.2-0.8% honey 25-35%, the composition is processed into a kind of beauty cream and oral liquid with special beauty effect by scientific formula. It has the effects of replenishing qi and blood, beautifying the face, anti-aging, and improving human immunity. Adhere to taking a small amount every day for more than 45 days, it can make the skin rosy and healthy, tender and shiny, and have the effect of anti-wrinkle and black hair.
6、<申请号>97107444<发明名称>一种滋补酒及其制备方法<申请人>四川康达建材工业(集团)公司,四川省威远县城区威玻路1号<文摘>本发明公开了一种滋补酒及其制备方法,其特征在于:组成成份包括:人参10-12克乌梢蛇9-11克首乌9-12克龙眼7.5-11克冰糖2克高梁酒500克矿泉水110克制备工艺是:A、原料处理a、首乌用朱沙炒制将朱沙用大火炒到80℃-150℃后,放入首乌继续翻炒,将首乌炒黄后,取出首乌,用毛刷刷去首乌上面的朱沙,用锤打碎成小块,b、将人参、乌梢蛇、龙眼切片或节或破碎成颗粒状,片状为30-60mm长,10-30mm厚,节状为50-100mm长,颗粒状的直径为10-30mm,B、浸制取汁将处理后的原料放入密封的容器中,用56-60度的优质高梁酒浸泡30-40天后,用皮管或酒泵将浸泡后的酒吸出,用70-120目的过滤布进行过滤,然后又加入50-60度的优质高梁酒继续浸泡30-40天,再用皮管或酒泵将浸泡后的酒吸出,取汁用70-120目的过滤,主要工艺过程是原料处理、浸泡取汁、勾兑、调味陈酿、检验包装,本发明具有口感舒适醇和,色泽感观好,制造成本低的优点,能滋阴壮阳,促进人体健康,富含多种对人体有益的营养元素。6. <Application No.> 97107444 <Invention Name> A Tonic Wine and Its Preparation Method <Applicant> Sichuan Kangda Building Materials Industry (Group) Company, No. 1 Weibo Road, Weiyuan County, Sichuan Province <Abstract> Disclosure of the Invention A nourishing wine and a preparation method thereof are characterized in that: the composition includes: 10-12 grams of ginseng, 9-11 grams of black snake, 9-12 grams of Shouwu 9-12 grams of longan, 7.5-11 grams of rock sugar, 2 grams of sorghum wine, 500 grams of mineral water The preparation process of 110 grams is: A. Raw material processing a. Stir-fry Shouwu with zhusha, stir-fry zhusha with high fire to 80°C-150°C, put Shouwu in and continue to stir-fry, fry Shouwu to yellow, take out Shouwu, Brush off the cinnabar on Shouwu with a brush, and break it into small pieces with a hammer. b. Slice or section or break ginseng, black snake, and longan into granules. The flakes are 30-60mm long and 10-30mm thick , the nodal shape is 50-100mm long, and the diameter of the granular shape is 10-30mm. B. Soaking and extracting the juice Put the processed raw materials in a sealed container and soak them in high-quality sorghum wine at 56-60 degrees for 30-40 days , use a leather tube or a wine pump to suck out the soaked wine, filter it with a 70-120 mesh filter cloth, and then add 50-60 degrees of high-quality sorghum wine to continue soaking for 30-40 days, and then use a leather tube or a wine pump to drain the wine The soaked wine is sucked out, and the juice is filtered with 70-120 mesh. The main process is raw material treatment, soaking and juice extraction, blending, seasoning and aging, and inspection and packaging. Advantages, it can nourish yin and strengthen yang, promote human health, and is rich in various nutritional elements beneficial to human body.
7、<申请号>97119951<发明名称>养生补液<申请人>周开威,辽宁省抚顺市新抚区福民街17委16组<发明人>周开威<文摘>本发明属于一种保健品,是针对人们容易缺少的营养素和药的调节机理,配以相应的中草药制成的,其主要成分由枸杞子、蚂蚁、仙茅、五加皮、龙眼肉、肉苁蓉、何首乌几味中草药和白酒组成,各组份的重量百分比是:以白酒为100%的组份,其它各味中草药的配比分别为:枸杞子4-5%;蚂蚁3-3.5%;仙茅2.5-3%;五加皮2.4-2.8%;龙眼肉2-2.4%;肉苁蓉2.4-2.8%;何首乌4-4.4%。该补液具有养气补血、养精固肾、强身壮阳、调节生理平衡之功能。7. <Application No.>97119951<Invention Name>Health Replenishing Liquid <Applicant> Zhou Kaiwei, Group 16, 17th Committee, Fumin Street, Xinfu District, Fushun City, Liaoning Province <Inventor> Zhou Kaiwei <Abstract> This invention belongs to a health care product, According to the regulation mechanism of nutrients and medicines that people tend to lack, it is made with corresponding Chinese herbal medicines. The percentage by weight of each component is: with white wine as 100% of the component, the proportioning ratios of other Chinese herbal medicines are respectively: wolfberry fruit 4-5%; ant 3-3.5%; curculigo curculigo 2.5-3%; 2.4-2.8%; Longan meat 2-2.4%; Cistanche 2.4-2.8%; Polygonum multiflorum 4-4.4%. The invigorating liquid has the functions of nourishing qi and blood, nourishing essence and strengthening the kidney, strengthening the body and strengthening yang, and regulating physiological balance.
8、<申请号>93110081<发明名称>增智健脑药<申请人>江西汇仁药业有限公司,江西省南昌市高新开发区火炬大街31号<文摘>增智健脑药是涉及增智健脑中药。本发明药物的主要组分是何首乌325-425g、柏子仁150-200g、龙眼肉100-150g、黄精325-425g、女贞子325-425g、桑椹325-425g、莲子150-200g、远志150-200g。本发明经药效学、毒理学及稳定性实验、临床验证是具有明显的补益心肾、养血调肝、健脑益智之功效,经临床观察治疗MR总有效率82%,治疗MBD总有效率96%。8. <Application No.> 93110081 <Invention Name> Brain-enhancing Medicine <Applicant> Jiangxi Huiren Pharmaceutical Co., Ltd., No. 31 Huoju Street, High-tech Development Zone, Nanchang City, Jiangxi Province Zhijian brain traditional Chinese medicine. The main components of the medicine of the present invention are Polygonum multiflorum 325-425g, Boziren 150-200g, Longan meat 100-150g, Polygonatum 325-425g, Ligustrum lucidum 325-425g, Mulberry 325-425g, Lotus seeds 150-200g, Polygala 150- 200g. Through pharmacodynamics, toxicology and stability experiments and clinical verification, the present invention has obvious effects of nourishing the heart and kidney, nourishing blood and regulating the liver, strengthening the brain and improving intelligence, and the total effective rate of treating MR is 82% through clinical observation, and the total effective rate of treating MBD is 82%. The effective rate is 96%.
9、<申请号>94102628<发明名称>精气神口服液的配制方法<申请人>陈长义,陕西省汉中市27号信箱<文摘>本发明属于一种中老年人保健强身的口服中药制剂。是将中药何首乌、生地、熟地、枸杞子、当归、杜仲、莲子、肉苁蓉、西洋参、牛膝、天麻、沉香、防风、桂圆肉、胡桃肉、黄芪、仙灵脾、鸡血藤、益智仁、砂仁、六神曲、菟丝子等中药按一定比例配制好后,混合煎取浓汁即成。精气神口服液具有很好的滋阴壮阳,益气和中,健脑怡神、乌须发、强筋骨、明眼目、泽肌肤、延年益寿的效果。经过20多年的临床观察,保健效果很好,而且无任何副作用。9. <Application No.> 94102628 <Invention Name> Jingqishen Oral Liquid Preparation Method <Applicant> Chen Changyi, Mailbox No. 27, Hanzhong City, Shaanxi Province <Abstract> The present invention belongs to an oral Chinese medicine preparation for health care and strengthening of middle-aged and elderly people. It is the traditional Chinese medicine Polygonum multiflorum, Rehmannia glutinosa, Rehmannia glutinosa, Lycium barbarum, Angelica, Eucommia ulmoides, Lotus seeds, Cistanche, American ginseng, Achyranthes bidentata, Gastrodia elata, agarwood, windproof, longan meat, walnut meat, astragalus, fairy spleen, Caulis Spatholobus, Yizhiren After the traditional Chinese medicines such as amomum, Liushenqu, and dodder are prepared in a certain proportion, they are mixed and decocted to obtain thick juice. Jingqishen Oral Liquid has the effects of nourishing yin and strengthening yang, nourishing qi and neutralizing the body, strengthening the brain and refreshing the mind, blackening the beard and hair, strengthening bones and muscles, improving eyesight, moisturizing the skin, and prolonging life. After more than 20 years of clinical observation, the health care effect is very good without any side effects.
从上述公开文献了解到,目前养气补血、滋阴、补虚、补肾的中药或保健品、饮料配方较复杂,有的有效成分不能充分发挥出来,只有是其制作过程还是沿用过去的老一套做法,或者用食用酒浸泡,或者进行简单的水提和煎煮得到,产品质量不易控制。From the above-mentioned published documents, it is understood that the traditional Chinese medicines or health care products and beverage formulas for nourishing qi and blood, nourishing yin, tonifying deficiency and tonifying kidney are relatively complex, and some active ingredients cannot be fully utilized. Either soak in edible wine, or carry out simple water extraction and decoction to obtain, and the product quality is difficult to control.
发明内容Contents of the invention
本发明的目的是提供一种对血虚,失眠针对性强、疗效显著,组方不复杂,原料来源较容易、生产量大、价格便宜、产品有效成分和稳定性较易控制、易检测的中成药和生产方法。The purpose of the present invention is to provide a kind of blood deficiency, insomnia specificity, remarkable curative effect, formula is not complicated, raw material source is relatively easy, production capacity is big, price is cheap, product active ingredient and stability are easy to control, easy to detect. Chinese patent medicines and production methods.
本发明的补血中药制剂其原料的主要活性成分是何首乌和龙眼肉,它是由以下重量份数的原料制成的:The main active ingredients of the raw materials of the blood-enriching traditional Chinese medicine preparation of the present invention are Polygonum multiflorum and longan meat, and it is made of the following raw materials in parts by weight:
何首乌4-10份,龙眼肉3-7份。4-10 parts of Polygonum multiflorum, 3-7 parts of longan meat.
所述的何首乌是未经制过的何首乌干片,也称赤何首乌,生何首乌。Described Radix Polygoni Multiflori is unprocessed Radix Polygoni Multiflori, also claims Radix Polygoni Multiflori Red, raw Polygonum multiflorum.
所述的龙眼肉是将新鲜水果龙眼肉不加入任何添加剂生晒得到的干品。The longan meat is a dry product obtained by drying the fresh fruit longan meat without adding any additives.
本药生产工艺流程中,何首乌炮制采用新的方法而不用传统的旧方法,何首乌的主要有效成分有三种:2、3、5、4’-四羟基二苯乙烯-β-D-葡萄糖甙,含量可高达1.2%,是控制质量的主要指标;磷脂,其中卵磷脂高达3.7%左右;羟基蒽醌类化合物,含量达1.1%。二苯乙烯为水溶性,磷脂在非极性溶剂和水中都具有很大的溶解度,蒽醌化合物结合型可溶于水而游离型难溶,生首乌与制首乌的功效和毒性差别很大,是由于制首乌经长时间高热后,化学成分发生了变化,如易溶的结合型蒽醌转变成难溶的游离型蒽醌,故生首乌有泻下作用而制首乌则无,另一方面,制首乌的毒性比生首乌明显降低,而滋补作用却明显加强,因此制首乌重在补血,而生首乌重在活血。传统中药何首乌炮制用焖蒸方法,即在生首乌中加黑豆汁(黑豆10kg,加水适量,煮约4小时,熬汁约15kg,豆渣再加水煮约3小时,熬汁约10kg,合并得黑豆汁约25kg),搅拌后,放罐内封严,置水锅内加热蒸煮32小时以上,九蒸九晒,内外均显棕褐色,乌黑发亮。本发明使用创新的高温高压法,将生(干)首乌切片(或粉碎),用水浸润后,放蒸气高压锅内,通蒸气使温度达118℃至124℃,6至10小时结束取出使用,可得同样效果。经多年的反复研究,比较对照,动物药效学、药理学、毒理学试验获得证明最佳效果,时间过长、温度过高,会使疗效降低,而时间过短、温度过低,也未获得制首乌疗效和清除毒性。经反复研究,从中精选药物组方,最终发明一种疗效好、组方较简化、容易控制工艺流程和质量、有效成分稳定性好、耗能少、价格便宜、原料来源丰富、适合于现代化工业生产、工艺先进的可行中成药。In the production process of this medicine, the processing of Polygonum multiflorum adopts new methods instead of traditional old methods. There are three main active ingredients of Polygonum multiflorum: 2, 3, 5, 4'-tetrahydroxystilbene-β-D-glucoside, The content can be as high as 1.2%, which is the main indicator of quality control; phospholipids, of which lecithin is as high as about 3.7%; hydroxyanthraquinone compounds, the content is 1.1%. Stilbene is water-soluble, phospholipids have great solubility in non-polar solvents and water, anthraquinone compound-bound forms are soluble in water but free forms are insoluble, and the efficacy and toxicity of raw and prepared Shouwu are very different. Large, because the chemical composition of Radix Polygoni Multiflori has changed after a long period of high heat, such as easily soluble bound anthraquinones into insoluble free anthraquinones. No, on the other hand, the toxicity of Shouwu is significantly lower than that of raw Shouwu, but the nourishing effect is significantly enhanced. Therefore, the focus of Shouwu is to replenish blood, while the focus of Shouwu is to activate blood. The traditional Chinese medicine Polygonum multiflorum is prepared by stewing and steaming, that is, black soybean juice (10kg of black soybeans, appropriate amount of water, boiled for about 4 hours, boiled for about 15kg of juice, boiled with soybean dregs for about 3 hours, boiled for about 10kg of juice, combined to obtain Black soybean juice (about 25kg), after stirring, put it in the tank and seal it tightly, put it in a water pot and cook it for more than 32 hours, steam nine times and dry it nine times, the inside and outside are tan, black and shiny. The present invention uses an innovative high-temperature and high-pressure method to slice (or crush) the raw (dry) Radix Polygoni Multiflori, soak it in water, put it in a steam pressure cooker, pass steam to make the temperature reach 118°C to 124°C, and take it out for use after 6 to 10 hours. The same effect can be obtained. After many years of repeated research and comparison, animal pharmacodynamics, pharmacology, and toxicology tests have proved the best results. If the time is too long and the temperature is too high, the curative effect will be reduced, and if the time is too short and the temperature is too low, it will not be effective. Obtain curative effect of Radix Polygoni Multiflori and eliminate toxicity. After repeated research, selected drug prescriptions from them, and finally invented a medicine with good curative effect, simplified prescription, easy control of process and quality, good stability of active ingredients, low energy consumption, cheap price, rich sources of raw materials, suitable for modernization Feasible Chinese patent medicine with advanced industrial production and technology.
何首乌和龙眼肉可以从《中国药典》和其它中药手册中查到其别名、拉丁名以及产地、用法。为了了解本发明治疗疾病的机理,现对处方中各味中药的功效、制法及在处方中的作用阐述如下:Polygonum multiflorum and longan meat can be found in the "Chinese Pharmacopoeia" and other traditional Chinese medicine manuals for their aliases, Latin names, origins, and usage. In order to understand the mechanism of the present invention's disease treatment, the effect, preparation method and the effect in the prescription of each flavor of Chinese medicine in the prescription are now set forth as follows:
龙眼肉,在广西称为桂圆,补益心脾、养血安神。用于气血不足,心悸怔忡,健忘失眠,血虚萎黄。何首乌制用,补肝肾,益精血,乌须发,强筋骨。用于血虚萎黄,眩晕耳鸣,须发早白,腰膝酸软,肢体麻木,崩漏带下,久疟体虚;高血脂。两药合用,补血补气和安神效果明显增强,并有降血液中胆固醇、提高血液高密度脂蛋白中胆固醇(HDL-C)的作用。Longan meat, known as longan in Guangxi, nourishes the heart and spleen, nourishes blood and calms the nerves. For insufficient qi and blood, palpitation, forgetfulness, insomnia, blood deficiency and chlorosis. Polygonum multiflorum is used to invigorate liver and kidney, benefit essence and blood, black beard and hair, and strengthen muscles and bones. Used for blood deficiency and chlorosis, dizziness and tinnitus, premature graying of beard and hair, soreness of waist and knees, numbness of limbs, metrorrhagia and vaginal discharge, chronic malaria and physical weakness; hyperlipidemia. The combined use of the two medicines can significantly enhance the effects of nourishing blood, invigorating qi and calming the nerves, and has the effect of lowering blood cholesterol and increasing blood high-density lipoprotein cholesterol (HDL-C).
虽然公开文献报道的中药制剂也有何首乌和龙眼肉,但为见将两者单独作为补血中药制剂的内容,而且何首乌的制作方法完全是采用新的方法,因而更能充分利用其有效成分。Although the traditional Chinese medicine preparations reported in the open literature also include Radix Polygoni Multiflori and longan meat, in order to see the content of the two alone as blood-enriching traditional Chinese medicine preparations, and the preparation method of Polygonum multiflorum is completely new, so that its active ingredients can be fully utilized.
上述组方可以为中医院治疗气血两虚、心悸怔忡、健忘失眠、头晕目眩、倦怠乏力、须发早白、腰膝酸软、肢体麻木、高血脂等症,供病人煎汤服用;更适合现代制药企业提取其有效成分,制成胶囊剂、颗粒剂、口服液、片剂等药剂学上的任何剂型,具体生产方法如下:The above-mentioned prescriptions can be used for the treatment of qi and blood deficiency, palpitations, forgetful insomnia, dizziness, fatigue, premature graying of beard and hair, soreness of the waist and knees, numbness of limbs, hyperlipidemia, etc., for patients to take as decoction; more suitable for modern Pharmaceutical companies extract its active ingredients and make capsules, granules, oral liquids, tablets and other pharmaceutical dosage forms. The specific production methods are as follows:
1.口服液的生产方法:1. The production method of oral liquid:
①.取何首乌(赤,生,干)切成薄片或粉碎,用水浸润数小时(4-6),放容器内,置蒸气高压锅内,通蒸气,控制温度在118℃至124℃,持续时间为6-10小时,取出冷却待用。①. Cut Polygonum multiflorum (red, raw, dry) into thin slices or crush it, soak it in water for several hours (4-6), put it in a container, put it in a steam pressure cooker, let it steam, and control the temperature at 118°C to 124°C. For 6-10 hours, take it out and cool it for later use.
②.制何首乌、龙眼肉,定量后,放煮药锅内,加5-8倍水,加热煮沸提取,2-3小时。取出药液,药渣再加适量水,加热煮沸提取,1-2小时。取出药液,将两次提取液合并。得中间提取液A液。②. Prepare Polygonum multiflorum and longan meat, after quantification, put it in a medicine pot, add 5-8 times of water, heat and boil for extraction, 2-3 hours. Take out the liquid medicine, add appropriate amount of water to the medicine dregs, heat and boil for extraction, 1-2 hours. Take out the medicinal solution and combine the two extracts. The intermediate extract solution A was obtained.
③.加热浓缩。将A液放浓缩锅内,加热浓缩,取出冷却,得中间提取液B液。③. Heating and concentration. Put the liquid A in the concentration pot, heat and concentrate, take it out and cool it, and obtain the middle extract liquid B.
④.乙醇沉淀。用95%乙醇加到B液中,95%乙醇与B液的比例(体积)为3∶1。混合。置4-8℃下静置24小时。过滤(去沉淀)。得中间提取液C液。④. Ethanol precipitation. Add 95% ethanol to solution B, the ratio (volume) of 95% ethanol to solution B is 3:1. mix. Let stand at 4-8°C for 24 hours. Filter (to precipitate). The middle extract liquid C was obtained.
⑤.回收乙醇。将C液放乙醇回收装置内,蒸气加热回收乙醇。取出回收液,加热浓缩,取出冷却,得药液D液。⑤. Recovery of ethanol. Put liquid C in the ethanol recovery device, and recover ethanol by steam heating. Take out the recovered liquid, heat it to concentrate, take it out and cool it, and obtain liquid D.
⑥.去单宁。在D液中加入适量3-5%食用明胶溶液,边加边搅拌,出现明显的白色混浊,到混浊不继续增加为止。置4℃-8℃冰箱内(或冷室内),静置16-24小时,过滤去沉淀。得滤液E液。⑥. Remove tannins. Add an appropriate amount of 3-5% edible gelatin solution into the D liquid, stir while adding, and obvious white turbidity appears until the turbidity does not continue to increase. Put it in a 4°C-8°C refrigerator (or in a cold room), let it stand for 16-24 hours, and filter to remove the precipitate. Obtain filtrate E liquid.
⑦.乙醇再沉淀。在E液中加入95%乙醇,E液与95%乙醇的比例为1∶3。搅拌混合。置4至8℃冰箱或冷室内,静置16至24小时。取出过滤,去沉淀。得滤液F液。⑦. Ethanol reprecipitation. Add 95% ethanol to liquid E, and the ratio of liquid E to 95% ethanol is 1:3. Stir to combine. Put it in a refrigerator or a cold room at 4 to 8°C, and let it stand for 16 to 24 hours. Take out and filter to remove the precipitate. Obtain filtrate F liquid.
⑧.回收乙醇。将F液放乙醇回收装置内,蒸气加热回收乙醇。将药液适当加热浓缩,得药液G液。⑧. Recovery of ethanol. Put liquid F in the ethanol recovery device, and recover ethanol by steam heating. Properly heat and concentrate the medicinal liquid to obtain medicinal liquid G.
⑨.取G液与适量糖浆等辅料混合,灌装,灭菌,得成品口服液。⑨. Take liquid G and mix it with an appropriate amount of syrup and other auxiliary materials, fill it, and sterilize it to obtain a finished oral liquid.
2.胶囊剂的生产方法:2. The production method of capsules:
①.何首乌炮制、药物提取、纯化等工艺流程同口服液。得G液。G液浓缩成流浸膏,喷雾干燥,得中间产品干膏粉H。①. Polygonum multiflorum processing, drug extraction, purification and other technological processes are the same as oral liquid. Get G liquid. Liquid G is concentrated into liquid extract, spray-dried to obtain dry cream powder H as an intermediate product.
②.取H与适量辅料混匀,制粒,装胶囊,包装,分装,得成品胶囊剂。②. Take H and mix with appropriate amount of auxiliary materials, granulate, pack into capsules, pack and subpackage to obtain finished capsules.
3.颗粒剂的生产方法:3. Production method of granules:
①.何首乌炮制、药物提取、纯化等工艺同胶囊剂,得干膏粉H。①. Polygonum multiflorum processing, drug extraction, purification and other processes are the same as capsules to obtain dry cream powder H.
②.取H与适量辅料混匀,制粒,干燥,分装,得成品颗粒剂。②. Mix H with appropriate amount of auxiliary materials, granulate, dry, and pack separately to obtain finished granules.
4.片剂的生产方法:4. The production method of the tablet:
①.何首乌炮制、药物提取、纯化工艺同胶囊剂,得流浸膏。①. The process of processing, extracting and purifying Polygonum Polygoni Multiflori is the same as that of capsules to obtain liquid extract.
②.取流浸膏与适量辅料混匀,制粒,压片,包装,得成品片剂。②. Take the liquid extract and mix with appropriate amount of auxiliary materials, granulate, compress into tablets, and pack to obtain finished tablets.
服用方法:How to use:
口服液,每天2-3次,每次10ml;胶囊剂,每天2-3次,每次2粒,每粒0.5克;颗粒剂,每天2-3次,每次1袋,每袋7克;片剂每天2-3次,每次2-3片,每片0.3克。Oral liquid, 2-3 times a day, 10ml each time; capsule, 2-3 times a day, 2 capsules each time, 0.5g each; granule, 2-3 times a day, 1 bag each time, 7g per bag ; Tablets 2-3 times a day, 2-3 tablets each time, 0.3 grams per tablet.
本发明与已有技术相比,其突出的实质性特点和显著的进步是:Compared with the prior art, the present invention's outstanding substantive features and remarkable progress are:
1.本发明在中医药理论指导下优选了上述中药,加以科学配伍,制作,相互配合,取长补短,协同作用,气血双补,镇静安神效果增强。同时,用药数量较少,有利于控制有效成分和产品稳定性。1. The present invention has optimized the above-mentioned Chinese medicine under the guidance of the theory of traditional Chinese medicine, scientific compatibility, making, cooperating with each other, learning from each other's strengths, synergistic effect, nourishing both qi and blood, and enhancing the calming and tranquilizing effect. At the same time, the amount of medication is small, which is conducive to the control of active ingredients and product stability.
2.本药制首乌,采用了全新的制备新方法,即高温高压法。与传统方法比较,其优点是时间短、耗能少、效率高,疗效不改变,更能充分利用其有效成分,适合于现代化中药工业大生产。本课题组于1988年开始研究本方法,1993年应用于工业大生产,经多年使用证明,本发明效率和疗效均显著。是先进的工业生产流程,可操作性强,适合现代化工业大生产。2. The preparation of Shouwu by this medicine adopts a brand-new preparation method, that is, high temperature and high pressure method. Compared with the traditional method, it has the advantages of short time, low energy consumption, high efficiency, no change in curative effect, and full use of its active ingredients, which is suitable for large-scale production in the modern Chinese medicine industry. Our research group began to study this method in 1988, and it was applied to large-scale industrial production in 1993. After years of use, it has been proved that the efficiency and curative effect of the present invention are remarkable. It is an advanced industrial production process with strong operability and is suitable for modern industrial mass production.
3.经实验和临床验证,本发明有补益心脾、益气养血之功效,适用于气血两虚、心悸怔忡、健忘失眠、头晕目眩、倦怠乏力等症,临床总有效率较高,(达94.2%)。3. Through experiments and clinical verification, the present invention has the effects of nourishing the heart and spleen, nourishing qi and nourishing blood, and is suitable for diseases such as deficiency of both qi and blood, palpitation, forgetfulness, insomnia, dizziness, fatigue and fatigue, and the total clinical effective rate is high. (up to 94.2%).
4.从现代医学的角度分析,本发明有提高血红蛋白(Hb)和红细胞数量,降低血清总胆固醇(T-Ch)、提高血清高密度脂蛋白中胆固醇含量,提高肝组织和血液中SOD活力。4. analyze from the angle of modern medicine, the present invention has improving hemoglobin (Hb) and erythrocyte quantity, reduces serum total cholesterol (T-Ch), improves cholesterol content in serum high-density lipoprotein, improves SOD activity in liver tissue and blood.
5.原料易得,组方科学,生产工艺先进,可操作性强。产品价格适中,适合工业化生产。5. The raw materials are easy to obtain, the formula is scientific, the production technology is advanced, and the operability is strong. The product is moderately priced and suitable for industrialized production.
6.生产中根据各中药的有效成分性质和制剂要求,采用水提、醇沉、明胶除毒成分,相应的灭菌方法的生产工艺,因而成品保留较高的有效成分,且不易变质,保存期长。6. In production, according to the properties of active ingredients and preparation requirements of each traditional Chinese medicine, water extraction, alcohol precipitation, gelatin detoxification ingredients, and corresponding sterilization methods are used in the production process, so that the finished product retains high active ingredients and is not easy to deteriorate. long term.
7.本发明的产品急性毒性研究和长期毒性研究和临床试验证明,按拟用日剂量和疗程使用本发明产品是安全的。7. Acute toxicity studies, long-term toxicity studies and clinical trials of the product of the present invention prove that it is safe to use the product of the present invention according to the intended daily dose and course of treatment.
具体实施方式Detailed ways
以下是本发明的实施例:The following are embodiments of the invention:
实施例一:Embodiment one:
称取以下中药成分(单位:g)Weigh the following traditional Chinese medicine ingredients (unit: g)
何首乌4,龙眼肉3,Polygonum multiflorum 4, longan meat 3,
①其生产步骤为:取何首乌(赤、干)片5g,用水浸润6小时,放容器内,置蒸气高压锅里,加热通蒸气,温度调至120℃,持续6小时,取出冷却,得制首乌。①The production steps are: take 5g of Radix Polygoni Multiflori (red, dry) slices, soak them in water for 6 hours, put them in a container, put them in a steam pressure cooker, heat them with steam, adjust the temperature to 120°C, continue for 6 hours, take them out and cool them down to obtain the first Wu.
②取以上制首乌,龙眼肉,加5-8倍水,加热煮沸提取2-3小时,倒药液出来,再加适量水,继续加热煮沸提取2小时。倒出药液,与前次的药液合并。得药液A液。②Take the Shouwu and longan meat prepared above, add 5-8 times of water, heat and boil for 2-3 hours, pour out the liquid medicine, add appropriate amount of water, continue to heat and boil for 2 hours to extract. Pour out the liquid medicine and combine with the previous liquid medicine. Get liquid A liquid.
③加热浓缩。将A液放在浓缩锅内,加热浓缩,至适量体积。得提取浓缩液B液。③ Heating and concentration. Put liquid A in the concentration pot, heat and concentrate to an appropriate volume. Obtained extract concentrate liquid B.
④乙醇沉淀。用95%乙醇与B液按体积比(3比1)混合,搅拌,置4-8冰箱或冰室内放置24小时。过滤去沉淀。得提取液C液。④Ethanol precipitation. Mix 95% ethanol with liquid B in a volume ratio (3:1), stir, and place in a 4-8 refrigerator or ice room for 24 hours. Filter to remove precipitate. Extract liquid C was obtained.
⑤回收乙醇。将C液放乙醇回收装置内,加热回收乙醇。取出药液,加热浓缩。得D液。⑤ recovery of ethanol. Put liquid C in the ethanol recovery device, and heat to recover ethanol. Take out the liquid medicine, heat and concentrate. Get liquid D.
⑥在D液中加3%-5%食用明胶溶液。边加边搅拌,出现明显的白色浑浊,至白色不继续增加为止。置4℃至8℃冰箱内,静置16-24小时。过滤去沉淀。得滤液E液。⑥Add 3%-5% edible gelatin solution to liquid D. While adding and stirring, obvious white turbidity appears until the white color does not continue to increase. Put it in a refrigerator at 4°C to 8°C, and let it stand for 16-24 hours. Filter to remove precipitate. Obtain filtrate E liquid.
⑦在E液中加入95%乙醇,乙醇与E液按3比1比例。搅拌,置4℃-8℃冰箱内,静置16至24小时。过滤去沉淀,得滤液F液。⑦ Add 95% ethanol to liquid E, and the ratio of ethanol to liquid E is 3:1. Stir, put in a refrigerator at 4°C-8°C, and let stand for 16 to 24 hours. Filter to remove the precipitate to obtain the filtrate F liquid.
⑧回收乙醇。将F液放乙醇回收装置内,加热回收乙醇。药液加热浓缩,得G液,加糖浆适量和辅料,灌装,封口,灭菌,得成品“元首口服液”(又名“乌圆补血胶囊”)。⑧ recovery of ethanol. Put liquid F in the ethanol recovery device, heat and recover ethanol. The medicinal liquid is heated and concentrated to obtain liquid G, which is added with an appropriate amount of syrup and auxiliary materials, filled, sealed, and sterilized to obtain the finished product "Head of Head Oral Liquid" (also known as "Wuyuan Buxue Capsule").
实施例二:Embodiment two:
称取以下中药成分:(单位:g)Weigh the following traditional Chinese medicine ingredients: (unit: g)
首乌6 龙眼肉4Shouwu 6 Longan Meat 4
其生产工艺流程为:Its production process is:
①何首乌的炮制,全部药物提取,纯化等按口服液,得G液。加热浓缩成流浸膏,喷雾干燥,得干膏粉H。①The processing of Radix Polygoni Multiflori, extracting and purifying all the medicines are taken as oral liquid to obtain liquid G. Heating and concentrating into liquid extract, spray drying, to obtain dry cream powder H.
②取干膏粉H,与适量辅料混合,制粒,装胶囊,用铝箔包装得成品,产品名称为“元首补血胶囊”。(又名“乌圆补血胶囊”)②Take the dry cream powder H, mix it with appropriate amount of auxiliary materials, granulate it, pack it into capsules, and pack it with aluminum foil to get the finished product. (Also known as "Wuyuan Buxue Capsule")
实施例三:Embodiment three:
称取以下中药成分:(单位:g)Weigh the following traditional Chinese medicine ingredients: (unit: g)
首乌8 龙眼肉5Shouwu 8 Longan Meat 5
其生产工艺流程为:Its production process is:
①何首乌的炮制,全部药物提取,纯化等工艺按元首补血胶囊,得干膏粉H。①The processing of Radix Polygoni Multiflori, all drug extraction, purification and other processes follow the procedures of Yuanshoubuxue Capsules to obtain dry cream powder H.
②取干膏粉H,与适量辅料混合,制粒,分装,包装得成品,每袋7g,产品名称为“元首补血颗粒”(又名“乌圆补血胶囊”)。②Take dry cream powder H, mix with appropriate amount of auxiliary materials, granulate, pack separately, and pack to obtain a finished product, 7g per bag, the product name is "Yuan Shou Xue Granules" (also known as "Wuyuan Buxue Capsules").
实施例四:Embodiment four:
称取以下中药成分:(单位:g)Weigh the following traditional Chinese medicine ingredients: (unit: g)
何首乌9 龙眼肉6Polygonum multiflorum 9 Longan meat 6
其生产工艺流程为:Its production process is:
①何首乌炮制工艺,全部药物提取、纯化按口服液。得G液。① Polygonum multiflorum processing technology, all medicines are extracted and purified according to oral liquid. Get G liquid.
②将G液浓缩成浸膏状。与蜂蜜或红糖等辅料混合,做成药丸,包装,药丸产品名称为“元首补血丸”(又名“乌圆补血胶囊”)。② Concentrate liquid G into extract. Mix with auxiliary materials such as honey or brown sugar, make pills, pack, and the name of the pill product is "Yuan Shou Bu Xue Pill" (also known as "Wuyuan Bu Xue Capsule").
实施例五:Embodiment five:
称取以下中药成分:(单位:g)Weigh the following traditional Chinese medicine ingredients: (unit: g)
何首乌10 龙眼肉7Polygonum multiflorum 10 Longan meat 7
其生产工艺流程为:Its production process is:
①何首乌炮制工艺,全部药物提取、纯化按口服液。得G液。① Polygonum multiflorum processing technology, all medicines are extracted and purified according to oral liquid. Get G liquid.
②将G液浓缩成浸膏状。与辅料混合,压片,包装,得成品产品名称为“元首补血片”(又名“乌圆补血胶囊”)。② Concentrate liquid G into extract. Mix with auxiliary materials, compress into tablets, pack, and the finished product name is "Head of Heads Buxue Tablets" (also known as "Wuyuan Buxue Capsules").
以下是本发明的临床研究报告:Following is the clinical research report of the present invention:
本发明药物委托省级三家医院(广西区人民医院,广西中医学院第一、第二附院)进行临床验证工作,工作步骤以及实验结果如下:The medicine of the present invention entrusts three provincial hospitals (People's Hospital of Guangxi District, the first and second affiliated hospitals of Guangxi College of Traditional Chinese Medicine) to carry out clinical verification work, and the working steps and experimental results are as follows:
临床资料clinical information
一、一般资料:1. General information:
治疗组和对照组210例,广西中医学院一附院观察70例,二附院观察70例,广西区人民医院观察70例。There were 210 cases in the treatment group and the control group, 70 cases were observed in the First Affiliated Hospital of Guangxi College of Traditional Chinese Medicine, 70 cases were observed in the Second Affiliated Hospital, and 70 cases were observed in the People's Hospital of Guangxi District.
所纳入之观察对象均为中医辨证属于心脾两虚证患者或气血两虚证患者,治疗组120例(心脾两虚与气血两虚证各60例)使用元首口服液。对照组90例(心脾两虚证60例,气血两虚证30例),使用百年乐口服液。治疗组与对照组性别、年龄分布均无显著性差异(P>0.05)。(见表1)。The included observation objects were all patients with TCM syndrome of deficiency of both heart and spleen or patients with deficiency of both qi and blood. In the treatment group, 120 cases (60 cases of deficiency of both heart and spleen and 60 cases of deficiency of both qi and blood) were given Yuanshou Oral Liquid. In the control group, 90 cases (60 cases with deficiency of both heart and spleen and 30 cases with deficiency of both qi and blood) were treated with Bainile Oral Liquid. There was no significant difference in gender and age distribution between the treatment group and the control group (P>0.05). (See Table 1).
二、诊断标准:2. Diagnostic criteria:
(一)、中医诊断标准:(1) TCM diagnostic criteria:
1、心脾两虚证:心悸怔忡、失眠多梦、健忘、食纳减少、脾胀、大便溏泻、倦怠乏力、舌质淡嫩、脉细弱。1. Deficiency of both heart and spleen: palpitations, insomnia, dreaminess, forgetfulness, decreased appetite, spleen distention, loose stools, fatigue, pale tongue, thready and weak pulse.
2、气血两虚证:少气懒言、乏力自汗、面色苍白、心悸失眠、头晕目眩、舌淡苔白、脉细弱。2. Deficiency of both qi and blood: lack of qi, lazy speech, fatigue and spontaneous sweating, pale complexion, palpitations, insomnia, dizziness, pale tongue with white coating, thready and weak pulse.
(二)、西医诊断标准:本证涉及的西医疾病参考《临床疾病诊断依据治愈好转标准》(2) Western medicine diagnostic criteria: Western medicine diseases involved in this syndrome refer to "Clinical Disease Diagnosis Based on Cure and Improvement Standards"
观察方法observation method
共观察210例,随机分为2组,其中治疗组120例,使用元首口服液,每次10ml,每日3次,连服4周。对照组90例,广西中医学院制药厂生产的百年乐口服液,每次15ml,每日3次,连服4周。试验前常规对受试者作详细体格检查,符合病例选择标准者即纳入观察对象。试验后每周随诊1次,询问服药情况,记录病情及副作用。气血两虚证者试验前后均查血常规。用证分法评定治疗效果。疗效判断由观察者作出。观察期间不用其他药物。A total of 210 cases were observed and randomly divided into 2 groups, of which 120 cases were in the treatment group, taking Fushou Oral Liquid, 10ml each time, 3 times a day, for 4 weeks. The 90 cases in the control group, the Bainile oral liquid produced by the pharmaceutical factory of Guangxi College of Traditional Chinese Medicine, 15ml each time, 3 times a day, for 4 weeks. A detailed physical examination was routinely performed on the subjects before the experiment, and those who met the case selection criteria were included in the observation objects. After the test, patients were followed up once a week to inquire about their medication and record their condition and side effects. Blood routine was checked before and after the test for those with Qi and blood deficiency syndrome. Evaluate the curative effect by syndrome method. Efficacy judgments were made by the observers. No other drugs were used during the observation period.
治疗结果treatment result
一、疗效评定标准:1. Criteria for evaluation of curative effect:
1、近期治愈:主症消失,见证积分减少91%以上。1. Short-term cure: the main symptom disappears, and the witness points decrease by more than 91%.
2、显效:主症改善2级,见证积分减少61-90%。2. Significant effect: the main symptoms are improved by 2 grades, and the witness points are reduced by 61-90%.
3、有效:主症改善1级,见证积分减少31-60%。3. Effective: the main symptoms are improved by 1 level, and the witness points are reduced by 31-60%.
4、无效:主症无改善,见证积分减少30%以下。4. Ineffective: No improvement in the main symptoms, and the witness score is reduced by less than 30%.
二、治疗结果:2. Treatment results:
1、对各种症状的影响:见表2。从表中可看出治疗组与对照组两种病症患者治疗后,各种见证积分下降均非常显著(P<0.01),提示两种药物对心脾两虚证心悸失眠、健忘、纳差、腹胀便溏,对气血两虚证之倦怠乏力、头晕目眩、心悸失眠等症状有明显改善作用。1. Effects on various symptoms: see Table 2. It can be seen from the table that after the treatment of patients with two diseases in the treatment group and the control group, the scores of various witnesses decreased very significantly (P<0.01), suggesting that the two drugs can effectively treat heart palpitations, insomnia, forgetfulness, anorexia, Abdominal distension and loose stools can significantly improve symptoms such as fatigue, dizziness, palpitations and insomnia of Qi and blood deficiency syndrome.
2、理化检查前后比较:见表2。从表中可看出两组患者外周血Hb、RBC治疗后均有明显增加,提示两组药物均能明显提高人血液Hb和RBC含量。2. Comparison before and after physical and chemical inspection: see Table 2. It can be seen from the table that the peripheral blood Hb and RBC of the two groups of patients all increased significantly after treatment, suggesting that the two groups of drugs can significantly increase the content of human blood Hb and RBC.
3、两组疗效比较:见表3。治疗组120例,总有效率为94.2%,对照组90例,总有效率为94.4%。两组疗效差异用Ri di分析法检验无显著意义(P>0.05)。3. Comparison of curative effect between the two groups: see Table 3. There were 120 cases in the treatment group, with a total effective rate of 94.2%, and 90 cases in the control group, with a total effective rate of 94.4%. There was no significant difference in curative effect between the two groups using Ri di analysis (P>0.05).
副作用side effect
两组患者在观察期间均未发生明显不良反应和毒副作用。No obvious adverse reactions and toxic side effects occurred in the two groups of patients during the observation period.
典型病例 Typical cases
例1.黄某,女性,45岁,因心悸气短半年就诊。患者自觉半年来心悸怔忡,伴有失眠、健忘、饮食减少、腹部胀痛、不思饮食、大便溏烂,一日两次,工作乏力。Example 1. Huang, female, 45 years old, went to the doctor for half a year due to palpitation and shortness of breath. The patient felt palpitations for half a year, accompanied by insomnia, forgetfulness, reduced diet, abdominal pain, no desire to eat, loose stools, twice a day, and fatigue at work.
检查:一般情况尚可,肺腹查未发现异常,舌质淡红,苔薄白,脉细弱。心电图正常。中医诊断:心悸(心脾两虚)。西医诊断:更年期综合症。给予元首口服液治疗,每次10ml,每天3次。服药1周后腹胀、食纳减少、大便溏烂等症状明显好转。服药2周后失眠、心悸减轻。3周后能正常入睡,大便转成形,每日1次。4周后,除仍有轻度心悸、健忘外,其余各症消失。疗效评定:显效。Inspection: the general condition is acceptable, no abnormality is found in the lung and abdomen examination, the tongue is light red, the fur is thin and white, and the pulse is thready and weak. Electrocardiogram was normal. Chinese medicine diagnosis: heart palpitations (deficiency of both heart and spleen). Western medicine diagnosis: menopausal syndrome. Give the head of state oral liquid treatment, each 10ml, every day 3 times. Symptoms such as abdominal distension, decreased appetite, and loose stools improved significantly after taking the medicine for 1 week. After taking the medicine for 2 weeks, the insomnia and palpitations were alleviated. After 3 weeks, I can fall asleep normally, and the stool turns into a shape, once a day. After 4 weeks, all symptoms disappeared except mild palpitation and forgetfulness. Efficacy evaluation: markedly effective.
例2.雷某,男性,40岁,因便血后头晕,乏力两个月就诊。患者两个月前因解柏油样便住院。诊为上消化道出血。经治疗后便血消失痊愈出院。但出院后仍是头晕乏力、尤以久蹲站起时明显。伴有心悸怔忡,气短懒言,动则汗出。检查:面色稍苍白,心肺腹检查未见异常。舌质淡,苔薄白,脉细弱。外周血Hb100g/L,RBC3.4×1012/L。中医诊断:眩晕(气血两虚)。西医诊断:失血性贫血。给予元首口服液治疗。每次10ml,每日3次。服药1周后自汗症状消失,其余症状减轻。3周后除仍有轻微心悸怔忡外,乏力、头晕、少气懒言等症状消失。疗程结束后,外周血复查:Hb120g/L,RBC4.0×1012/L。疗效评定:显效。Example 2. Lei Mou, male, 40 years old, went to the doctor for two months due to dizziness and fatigue after having blood in the stool. The patient was hospitalized two months earlier with tarry stools. Diagnosed as upper gastrointestinal bleeding. After treatment, the blood in stool disappeared and he was discharged from hospital. However, after being discharged from the hospital, he was still dizzy and weak, especially when he squatted and stood up for a long time. Accompanied by palpitations, shortness of breath and lazy speech, and sweating when moving. Examination: complexion is slightly pale, no abnormality is found in cardiopulmonary abdominal examination. Pale tongue, thin white fur, thready and weak pulse. Peripheral blood Hb100g/L, RBC3.4×10 12 /L. Chinese medicine diagnosis: dizziness (deficiency of both Qi and blood). Western medicine diagnosis: hemorrhagic anemia. Give the head of state oral liquid treatment. 10ml each time, 3 times a day. After taking the medicine for 1 week, the spontaneous sweating symptom disappeared, and the remaining symptoms were alleviated. After 3 weeks, in addition to still having slight palpitations, symptoms such as fatigue, dizziness, lack of breath and lazy speech disappeared. After the course of treatment, peripheral blood re-examination: Hb120g/L, RBC4.0×10 12 /L. Efficacy evaluation: markedly effective.
小结Summary
以上资料提示:The above information prompts:
1、元首口服液具有宁心健脾、补气益血之功效,可用于劳伤心脾,气血不足所至之心悸怔忡、失眠多梦、倦怠乏力、头晕目眩等症。1. Yuanshou Oral Liquid has the effects of calming the heart, invigorating the spleen, invigorating qi and blood, and can be used for heart palpitations, insomnia, dreaminess, fatigue, fatigue, dizziness and other symptoms caused by fatigue, heartburn, and insufficient qi and blood.
2、元首口服液能提高人体血液中血红蛋白及红血球含量。2. Head of State Oral Liquid can increase the content of hemoglobin and red blood cells in human blood.
3、本组120例,总有效率94.2%,疗效与广西中医学院药厂生产的百年乐口服液无显著差异。3. There were 120 cases in this group, the total effective rate was 94.2%, and the curative effect was not significantly different from that of Bainile Oral Liquid produced by Guangxi College of Traditional Chinese Medicine Pharmaceutical Factory.
4、本品安全可靠,120例,在观察期间未发现明显不良反应及毒副作用。4. This product is safe and reliable, 120 cases, no obvious adverse reactions and side effects were found during the observation period.
表1.治疗组与对照组性别(例),年龄(X±SD)比较 Table 1. Treatment group and control group gender (example), age (X±SD) comparison
治疗组 对照组
男 女 年龄 男 女 年龄Male Female Age Male Female Age
心脾两虚 26 34 45.28±11.79 30 30 46.77±11.40Deficiency of heart and spleen 26 34 45.28±11.79 30 30 46.77±11.40
气血两虚 23 37 46.37±12.93 10 20 42.20±11.50Qi and blood deficiency 23 37 46.37±12.93 10 20 42.20±11.50
两组性别、年龄比较,P值均>0.05Comparison of gender and age between the two groups, all P values > 0.05
表2 治疗前后见证积分及理化检查比较(X±SD) Table 2 Comparison of witness scores and physical and chemical examinations before and after treatment (X±SD)
治疗组 对照组
n 治疗前 治疗后 n 治疗前 治疗后n Before treatment After treatment n Before treatment After treatment
心脾两虚证:Deficiency of both heart and spleen:
心悸 51 2.69±1.13 1.01±0.77 54 3.10±1.20 1.20±0.87Palpitations 51 2.69±1.13 1.01±0.77 54 3.10±1.20 1.20±0.87
失眠 56 3.40±0.93 1.20±0.94 53 3.30±0.97 1.27±0.79Insomnia 56 3.40±0.93 1.20±0.94 53 3.30±0.97 1.27±0.79
健忘 57 2.63±1.00 1.52±0.86 58 3.02±1.05 1.63±0.90Forgetful 57 2.63±1.00 1.52±0.86 58 3.02±1.05 1.63±0.90
纳差 37 2.32±1.07 0.70±0.70 53 2.88±1.03 0.70±0.68Anorexia 37 2.32±1.07 0.70±0.70 53 2.88±1.03 0.70±0.68
腹胀 34 1.76±1.26 0.54±0.73 39 1.98±1.27 0.61±0.69Abdominal distension 34 1.76±1.26 0.54±0.73 39 1.98±1.27 0.61±0.69
便溏 41 1.76±0.97 0.50±0.66 37 1.99±0.67 0.54±0.61Loose stool 41 1.76±0.97 0.50±0.66 37 1.99±0.67 0.54±0.61
气血两虚证:Qi and blood deficiency syndrome:
少气懒言 57 3.32±1.00 1.17±0.72 27 3.50±0.85 1.00±1.10Less angry and lazy 57 3.32±1.00 1.17±0.72 27 3.50±0.85 1.00±1.10
乏力 60 1.43±0.97 1.63±0.94 58 4.33±0.92 1.67±1.09Fatigue 60 1.43±0.97 1.63±0.94 58 4.33±0.92 1.67±1.09
面色苍白 53 2.03±0.91 1.51±0.82 29 3.40±1.07 1.23±0.83Pale 53 2.03±0.91 1.51±0.82 29 3.40±1.07 1.23±0.83
心悸 51 2.94±1.03 0.67±0.77 28 2.90±1.13 0.63±0.03Palpitations 51 2.94±1.03 0.67±0.77 28 2.90±1.13 0.63±0.03
失眠 42 2.34±1.19 0.91±0.88 20 2.47±1.47 1.02±0.96Insomnia 42 2.34±1.19 0.91±0.88 20 2.47±1.47 1.02±0.96
头晕目眩 54 3.98±0.95 1.79±0.68 30 4.73±0.93 2.07±0.94Dizziness 54 3.98±0.95 1.79±0.68 30 4.73±0.93 2.07±0.94
Hb(g/L) 60 108.52±14.72 117.33±13.8 30 100.20±10.19 114.27±10.19Hb(g/L) 60 108.52±14.72 117.33±13.8 30 100.20±10.19 114.27±10.19
RBC(10/L) 60 3.56±0.39 3.84±0.31 30 3.32±0.40 3.03±0.46RBC(10/L) 60 3.56±0.39 3.84±0.31 30 3.32±0.40 3.03±0.46
表3 治疗组与对照组疗效比较(Ridit)分析 Table 3 Comparison of curative effect between the treatment group and the control group (Ridit) analysis
n 痊愈 显效 有效 无效 R U P ,
心脾两虚证Syndrome of Deficiency of Heart and Spleen
治疗组 60 3 25 29 3 0.4582Treatment group 60 3 25 29 3 0.4582
1.5862 >0.051.5862 > 0.05
对照组 60 6 31 21 2 0.5418Control group 60 6 31 21 2 0.5418
气血两虚证Qi and blood deficiency syndrome
治疗组 60 2 32 22 4 0.4930Treatment group 60 2 32 22 4 0.4930
0.3269 >0.05...
对照组 30 4 13 10 3 0.5141Control group 30 4 13 10 3 0.5141
总疗效total curative effect
治疗组 120 5 57 51 7 0.4760Treatment group 120 5 57 51 7 0.4760
1.3937 >0.05
对照组 90 10 44 31 5 0.5321Control group 90 10 44 31 5 0.5321
临床研究负责人:Clinical research leader:
广西中医学院一附院中西医结合副主任医师 周文光Zhou Wenguang, Deputy Chief Physician of Integrated Traditional Chinese and Western Medicine in the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
各临床负责人:Each clinical leader:
广西中医学院一附院副主任医师 周德丽Zhou Deli, Deputy Chief Physician of the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
广西中医学院二附院副主任医师 何 辉He Hui, Deputy Chief Physician of the Second Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
广西区人民医院副主任医师 刘庆芬Liu Qingfen, Deputy Chief Physician, People's Hospital of Guangxi District
实验研究:Experimental Study:
元首口服液对小白鼠HDL-C和LCAT的影响Effect of Yuanshou Oral Liquid on HDL-C and LCAT of Mice
(研究人员:张树球、黄运忠、卢彩珍、李民)(Researchers: Zhang Shuqiu, Huang Yunzhong, Lu Caizhen, Li Min)
动物:小白鼠,昆明种,体重18-22g,健康,66只小鼠分成三组:实验一组,实验二组,对照组。Animals: mice, Kunming species, healthy, weighing 18-22g, 66 mice were divided into three groups: experimental group 1, experimental group 2, and control group.
给药方法:实验一组按成人量8倍、二组按成人量2倍剂量给药,灌胃,每天一次。连续30天。对照组灌蒸馏水,相同体积。Dosing method: the experimental group was given 8 times the adult dose, and the second group was given 2 times the adult dose, intragastrically, once a day. 30 consecutive days. The control group was perfused with distilled water with the same volume.
测定方法:test methods:
实验结束,从眼球取血,分离血清,测定高密度脂蛋白中胆固醇(HDL-C)和卵磷脂胆固醇脂酰基转移酶(LCAT)活性。At the end of the experiment, blood was taken from the eyeball, the serum was separated, and the activities of high-density lipoprotein cholesterol (HDL-C) and lecithin cholesterol acyltransferase (LCAT) were measured.
实验结果:Experimental results:
表1 实验组与对照组HDL-C含量比较(单位:mmoL/L) Table 1 Comparison of HDL-C content between the experimental group and the control group (unit: mmoL/L)
组别 例数 HDL-C(X±SD) P值Groups Number of cases HDL-C(X±SD) P value
实验一组 22 3.74±1.82 P<0.01Experimental group 22 3.74±1.82 P<0.01
实验二组 22 3.06±0.70 P<0.01Experimental group 2 22 3.06±0.70 P<0.01
对照组(鼠) 22 1.95±1.00Control group (rat) 22 1.95±1.00
对照组(人) 22 1.33±0.71Control group (human) 22 1.33±0.71
实验组HDL-C均明显高于对照组,(P<0.01)The HDL-C of the experimental group was significantly higher than that of the control group (P<0.01)
表2 小鼠血清LCAT活性比较(mmol/m·h-1)Table 2 Comparison of LCAT activity in mouse serum (mmol/m·h -1 )
组别 n 酶活性单位 P值Group n Enzyme activity unit P value
实验组 21 8.45Experimental group 21 8.45
对照组 21 4.13 <0.01Control group 21 4.13 <0.01
实验组LCAT明显高于对照组(P<0.01)。The LCAT of the experimental group was significantly higher than that of the control group (P<0.01).
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410013167 CN1287827C (en) | 2004-05-14 | 2004-05-14 | Blood-supplementing traditional Chinese medicine preparation and its production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410013167 CN1287827C (en) | 2004-05-14 | 2004-05-14 | Blood-supplementing traditional Chinese medicine preparation and its production method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1579482A true CN1579482A (en) | 2005-02-16 |
CN1287827C CN1287827C (en) | 2006-12-06 |
Family
ID=34581669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410013167 Expired - Lifetime CN1287827C (en) | 2004-05-14 | 2004-05-14 | Blood-supplementing traditional Chinese medicine preparation and its production method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1287827C (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008647B (en) * | 2009-09-09 | 2011-12-14 | 刘皇琼 | Traditional Chinese medicine for treating lymphangioleiomyomatosis and preparation method thereof |
CN101843891B (en) * | 2009-03-27 | 2012-06-06 | 哈药集团制药六厂 | Blood tonifying composition |
CN102526316A (en) * | 2012-01-18 | 2012-07-04 | 张树球 | Chinese medicinal formulation for preventing and treating senile dementia and production method thereof |
CN103315360A (en) * | 2013-06-21 | 2013-09-25 | 方希修 | Radix cynanchi bungei granule and preparation method thereof |
CN103892274A (en) * | 2013-08-19 | 2014-07-02 | 周俊 | Method for preparing composite blood replenishing tablet from dry longan pulp |
CN104623266A (en) * | 2014-12-08 | 2015-05-20 | 黄平县兴且民族民间中草医药科学发展有限责任公司 | Traditional Chinese medicine formula for enriching heart blood |
CN108295233A (en) * | 2018-04-11 | 2018-07-20 | 丹阳市上古本真健康科技有限公司 | Chinese medicine of blood-supplementing blood-nourishing and preparation method thereof |
-
2004
- 2004-05-14 CN CN 200410013167 patent/CN1287827C/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101843891B (en) * | 2009-03-27 | 2012-06-06 | 哈药集团制药六厂 | Blood tonifying composition |
CN102008647B (en) * | 2009-09-09 | 2011-12-14 | 刘皇琼 | Traditional Chinese medicine for treating lymphangioleiomyomatosis and preparation method thereof |
CN102526316A (en) * | 2012-01-18 | 2012-07-04 | 张树球 | Chinese medicinal formulation for preventing and treating senile dementia and production method thereof |
CN103315360A (en) * | 2013-06-21 | 2013-09-25 | 方希修 | Radix cynanchi bungei granule and preparation method thereof |
CN103892274A (en) * | 2013-08-19 | 2014-07-02 | 周俊 | Method for preparing composite blood replenishing tablet from dry longan pulp |
CN104623266A (en) * | 2014-12-08 | 2015-05-20 | 黄平县兴且民族民间中草医药科学发展有限责任公司 | Traditional Chinese medicine formula for enriching heart blood |
CN108295233A (en) * | 2018-04-11 | 2018-07-20 | 丹阳市上古本真健康科技有限公司 | Chinese medicine of blood-supplementing blood-nourishing and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1287827C (en) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1545382A (en) | Method for processing ginseng and the uses of extract of processed ginseng | |
CN1646150A (en) | Novel use of the extract of processed ginseng and saponin isolated therefrom | |
CN1263494C (en) | Granule for treating puerperal galactozemia and its preparation method | |
CN1119164C (en) | Medicine for treating chronic incomplete renal function and its prepn | |
CN1565552A (en) | Chinese traditional medicine for treating immune hypofunction and disfunction | |
CN103749735A (en) | Instant sugar-free high GABA (Gamma Amino Acid Butyric Acid) folium mori uncongealed beancurd and preparation method thereof | |
CN1287827C (en) | Blood-supplementing traditional Chinese medicine preparation and its production method | |
CN114042126B (en) | A traditional Chinese medicine composition for raising qing, removing turbidity, removing dampness, nourishing qi, slimming and lipid-lowering and preparation method thereof | |
CN1191082C (en) | Chinese medicinal composition for treating fatty liver and its preparation method | |
CN101574476B (en) | Medicinal composition for auxiliary lipid lowering and liver protection | |
CN1232267C (en) | Compound plant medicine and its application | |
CN108142766A (en) | A kind of dendrobium candidum beverage and preparation method thereof | |
CN1559495A (en) | Deer's fetus granular Chinese madicinal preparation and its production technology | |
CN101036722A (en) | Health-caring food for easing and improving climacteric Syndrome of men and the preparation thereof | |
CN101411375B (en) | Cold tea for preventing and treating coprostasis type sub-health and preparation method thereof | |
CN1660233A (en) | Traditional Chinese medicine for conditioning the body and nourishing the body | |
CN1202843C (en) | Drug rehabilitation oral liquid | |
CN1211111C (en) | Antilipemic Chinese medicine | |
CN1526440A (en) | Compound Chinese medicine prepn for treating muscular atrophy and amyasthenia and its prepn process | |
CN1222305C (en) | Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method | |
CN1899581A (en) | Medicinal composition for treating qi stagnation and cold stasis stomach-ache and its preparing method and use | |
CN1126616A (en) | Oral liquid containing biological product of snail and turtle and Chinese medicine prepn and its prepn process | |
CN100428897C (en) | Health care food for antifatigue and improving subhealthy and its preparation method | |
CN100344304C (en) | Traditional Chinese medicine preparation for treating consumptive disease and preparation method thereof | |
CN1069836C (en) | Medicine for curing infantile malnutrition and its preparing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220329 Address after: 533011 room 507, 5 / F, building 8, phase II standard plant, No. 6, Yinhai Road, Youjiang District, Baise City, Guangxi Zhuang Autonomous Region Patentee after: Guangxi Yunqiu Biotechnology Co.,Ltd. Address before: 533000 No. 98 urban-rural Road, the Guangxi Zhuang Autonomous Region, Baise Patentee before: YOUJIANG MEDICAL University FOR NATIONALITIES |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20061206 |